Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

The first dominant SARS‐CoV‐2 Omicron variant BA.1 harbours 35 mutations in its Spike protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon after its discovery, BA.1 rapidly emerged to become the dominant variant worldwide and has since evolved into several variants. Omicron is o...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Reviews in medical virology Ročník 32; číslo 5; s. e2381 - n/a
Hlavní autoři:	Shrestha, Lok Bahadur, Foster, Charles, Rawlinson, William, Tedla, Nicodemus, Bull, Rowena A.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Wiley Periodicals Inc 01.09.2022 John Wiley and Sons Inc
Témata:	Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antibodies, Neutralizing Antibodies, Viral COVID-19 Evolution Humans Immune evasion Infectivity Monoclonal antibodies Mutation omicron Public health Recombination Review SARS-CoV-2 - genetics SARS‐COV‐2 Severe acute respiratory syndrome coronavirus 2 Spike protein Syncytia Vaccines omicron immune evasion SARS-COV-2 monoclonal antibodies
ISSN:	1052-9276, 1099-1654, 1099-1654
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!